SCHEMBL19248147

SCHEMBL19248147

Clc1ccc(-c2nc(-c3ccccc3)nc3c2sc2ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ ADORA3 P0DMS8 2/20 0.44
▸ ADORA1 P30542 2/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HPGD P15428 3/20 0.41
▸ NPSR1 Q6W5P4 3/20 0.41
▸ PTGDR2 Q9Y5Y4 2/20 0.40
▸ ATM Q13315 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ GBA1 P04062 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30775145 1.00 DPP4 (0.46) DPP4ALDH1A1MEN1KMT2AADORA3
SCHEMBL19136191 1.00 DPP4 (0.46) DPP4ALDH1A1MEN1KMT2AADORA3
SCHEMBL18017759 0.93 MEN1 (0.45) DPP4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL18017848 0.93 MEN1 (0.45) DPP4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL18017854 0.93 MEN1 (0.45) DPP4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL18017815 0.92 MEN1 (0.44) DPP4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL18017762 0.92 MEN1 (0.44) DPP4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL18158403 0.92 MEN1 (0.48) DPP4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL18017908 0.92 MEN1 (0.44) DPP4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL18017898 0.92 MEN1 (0.44) DPP4ALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021034081-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 솔루스첨단소재 주식회사 2021-02-25 — — WO disclosed
WO-2021034081-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 솔루스첨단소재 주식회사 2021-02-25 — — WO disclosed
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 — — US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 — — US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNA1, ARL1 DPP4 4871/4885ALDH1A1 139/4885MEN1 324/4885
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNA1, ARL1 DPP4 4871/4885ALDH1A1 139/4885MEN1 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback